A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
Clinicaltrials.gov Identifier:All clinical trials available on ClinicalTrials.gov are given an official number by the United States government. This helps people easily search for and find a certain trial.
Trial details
How far along a trial is in the process. There are several phases: Phase 1, Phase 2, Phase 3 and Phase 4.
Trials that are looking for healthy people to participate.
The disease(s) being studied in a trial.
Neoplasms
An interventional trial typically studies a potential medicine. An observational trial watches a person's health over time with no investigational medicine given.
Interventional
The new medicine being studied.
aflibercept (AVE0005), S-1
The number of people the researchers want in the trial.
22
Trial summary
The primary objective of this study is to determine the recommended phase II dose of AVE0005 in combination with S-1 in Japanese cancer patients.
The secondary objectives of this study are to assess the safety profile of AVE0005, to determine the pharmacokinetics of AVE0005, to make a preliminary assessment of antitumor effects.
Trial locations
0 location(s)